BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 08/08/2005

International Conference on Harmonisation; Draft Guidance on Q9 Quality Risk Management; Availability

The Food and Drug Administration (FDA) is announcing the availability of a draft guidance entitled "Q9 Quality Risk Management." The draft guidance was prepared under the auspices of the International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH). The draft guidance provides principles and examples of tools for quality risk management that can be applied to all aspects of pharmaceutical quality throughout the lifecycle of drug substances, drug products, and biological and biotechnological products. The draft guidance is intended to enable regulators and industry to make more effective and consistent risk- based decisions.

Source: Federal Register — Food and Drug AdministrationOpen original release →